Mozz, the key difference is that Tanenzumab made a lot of sense to BP given it was an extremely effective pain killer and they could control it.
The world has moved on clearly and the previous thought bubble from PAR "align with parties that share our values" is now more akin to "desperate to do a deal and asking Beverley every day"
IMO PAR will rest everyone's thesis over the coming month or 2 once it become apparent how commercial it is to repurpose a drug. Happy to be proven wrong.
Mozz, the key difference is that Tanenzumab made a lot of sense...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $71.79M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.5¢ | 19.5¢ | $29.16K | 144.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 75495 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 16469 | 2 |
View Market Depth
| Last trade - 11.16am 02/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |